| Date | Title | Description |
| 27.07.2026 | TriNetX Appoints August Calhoun Chief Executive Officer | Jeff Margolis Resumes Chairman Role as Company Completes CEO Transition
CAMBRIDGE, Mass., July 27, 2026 /PRNewswire/ -- TriNetX, The Global Truth Engine for Better Human Health™ and operator of the world's leading federated health data netw... |
| 01.07.2026 | Студенты-медики массово выпускают сомнительные исследования с помощью популярного инструмента | Критики считают, что TriNetX позволяет слишком легко анализировать электронные медицинские карты, из-за чего неопытные исследователи быстро публикуют плохо проработанные статьи.
Каждое утро Джошуа Ван садится за компьютер с булочкой и банко... |
| 27.06.2026 | EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss | GENEVA, June 27, 2026 /PRNewswire/ -- Adults with both epilepsy and hearing loss who use hearing aids may have a 23% lower risk of developing dementia than those who do not, according to new research presented at the European Academy of Neu... |
| 23.06.2026 | TriNetX LIVE™ Network Surpasses 300 Million Patients, Expanding Decision-Grade Evidence Across Global Healthcare | The milestone reflects accelerating international growth and gives pharmaceutical companies, academic researchers, healthcare providers, and health-tech innovators access to trusted, current, clinically rich, and globally representative rea... |
| 19.06.2026 | 52% — это цифра, которую дизайнерам стоит знать | В январе Stanford Medicine опубликовала в Nature Health исследование, которое мне теперь сложно перестать обсуждать на дизайн-ревью. Краткое содержание: у людей с дальтонизмом, заболевших раком мочевого пузыря, смертность за 20 лет на 52% в... |
| 07.04.2026 | TriNetX Enhances its Ability to Federate Genomics Data Across its Global Network of Providers through the Acquisition of Key Assets of Zetta Genomics | TriNetX® will continue to support all existing Zetta Genomics customers utilizing the award-winning XetaBase® technology for research and patient care innovation
CAMBRIDGE, Mass. and CAMBRIDGE, United Kingdom, April 7, 2026 /PRNewswire/ -- ... |
| 03.04.2026 | TriNetX Collaborates with Regeneron to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions | Regeneron has exclusive opportunity to connect large-scale genomic and proteomic data cohorts to TriNetX's industry-leading global network of electronic health record data
Collaboration will expand Regeneron's world-leading genomic and prot... |
| 23.01.2026 | TriNetX Unveils Conversational AI Interface and Enhanced API Capabilities | , driven by its vision of a connected world where data and intelligence power improved human health, announced results demonstrating its TriNetX LIVE™ platform is transforming how pharmaceutical companies design and execute clinical trials.... |
| 15.10.2025 | TriNetX Becomes the Most Cited Real-World Data Source in Peer-Reviewed Research | With more than 2,000 citations and year-over-year growth nearing 80%, TriNetX outpaces competitors and fuels high-impact science published in top medical journals.
CAMBRIDGE, Mass., Oct. 15, 2025 /PRNewswire/ -- TriNetX, driven by its visio... |
| 29.09.2025 | TriNetX Named Among the Top 25 Healthcare Software Companies of 2025 | Recognition by The Healthcare Technology Report underscores TriNetX's innovation in real-world data, artificial intelligence, and clinical research transformation.
CAMBRIDGE, Mass., Sept. 29, 2025 /PRNewswire/ -- TriNetX, the company behind... |
| 27.05.2025 | Building Breakthroughs: How Research-Ready Data Transforms Clinical Development, Upcoming Webinar Hosted by Xtalks | www.trinetx.com
In this free webinar, learn how data integrity directly impacts research outcomes. Attendees will gain insight into what it takes to ensure data is truly research-ready. The featured speaker will discuss how expanding access... |
| 03.03.2025 | Overcoming Challenges in Clinical Trial Completion, Upcoming Webinar Hosted by Xtalks | www.trinetx.com
In this free webinar, learn about implementing strategies that prioritize the participant's experience and improve overall trial outcomes. Attendees will understand the difficulties in enrolling and keeping participants enga... |
| 14.02.2025 | Kauvery Hospital invests in AI RPM startup and more briefs | Photo: Martin Barraud/Getty Images
Kauvery Hospital invests in Lifesigns
Lifesigns has received undisclosed funding from Kauvery Hospital Group's investment arm, Healthcare Capital.
The new funds, based on a press statement, will "adva... |
| 12.02.2025 | TriNetX and Fujitsu Launch Joint Venture to Increase Japanese Patients' Access to Life-Changing Medicines | Partnership taps real-world data to accelerate clinical trials, research, and drug development in Japan.
CAMBRIDGE, Mass., Feb. 12, 2025 /PRNewswire/ -- TriNetX, a global leader in real-world data (RWD) and real-world evidence (RWE) solutio... |
| 10.01.2025 | TriNetX's Founding CEO Announces Plans to Step Down | After 11 Years, Gadi Lachman to Conclude Operating Role, Remain on TriNetX's Board
CAMBRIDGE, Mass., Jan. 9, 2025 /PRNewswire/ -- TriNetX, the largest global source of real-world data, today announced that Gadi Lachman, the Company's Founde... |
| 28.10.2024 | Navigating the FDA's New Clinical Trial Diversity Guidance: Unlocking the Future of Inclusive Research, Upcoming Webinar Hosted by Xtalks | www.trinetx.com
In this free webinar, learn about the latest FDA guidelines on diversity in clinical trials, including the new requirements for diversity action plans and their impact on study design and outcomes. Attendees will gain insigh... |
| 08.10.2024 | RWD to the Rescue: Solving R&D Challenges for Pharma Companies, Upcoming Webinar Hosted by Xtalks | www.trinetx.com
In this free webinar, learn about using real-world data (RWD) to power the design of asset strategies and clinical trials. Attendees will gain insights into leveraging RWD to gain insights into cohorts, endpoints, feasibilit... |
| 19.09.2024 | Resilience in adversity: Ukraine's tech ecosystem | Ukraine's startup ecosystem has changed in the last two years, creating a landscape that is markedly different from the pre-conflict environment.
Startups are prioritizing solutions to basic needs such as security, internet access, and elec... |
| 05.07.2024 | Health | Rate of young women getting sterilized doubled after Roe was overturned | After Roe was overturned in June 2022, doctors said a wave of young people like Ferst started asking for permanent birth control like tubal ligations, in which the fallopian tubes are removed, or vasectomies.
New research published this spr... |
| 19.03.2024 | Takeda Hospital Group Joins TriNetX Network to Revolutionize Medical Care in Japan | CAMBRIDGE, Mass., March 19, 2024 /PRNewswire/ -- Takeda Hospital Group, a leading healthcare provider in Kyoto, Japan Prefecture, has joined the TriNetX, LLC (TriNetX) network.
Recognizing the need for tailored treatments based on the disti... |
| 04.10.2023 | Ukraine's Trinetix plans LatAm expansion after $10M investment | This week Ukraine-founded product development company Trinetix announced today it has secured $10 million in funding from the Kyiv-based investment fund Hypra.
Trinetix is a digital product partner to enterprises and fast-growing brands, em... |
| 07.03.2023 | Japan's Saitama Medical University International Medical Center Joins the TriNetX Network to Study Global Real-World Data on Rare Diseases, Treatments, and Outcomes to Benefit Its Patients | CAMBRIDGE, Mass., March 7, 2023 /PRNewswire/ -- Saitama Medical University International Medical Center, one of Japan's leading hospitals for the treatment of oncology, cardiology, and stroke cases, has joined the TriNetX Network to utilize... |
| 27.02.2023 | Japan's Omi Medical Center, Seikoukai, Becomes the First Healthcare Organization in Western Japan to Sign a Partnership Agreement with TriNetX to Increase Participation in Multi-National Clinical Tria... | CAMBRIDGE, Mass., Feb. 27, 2023 /PRNewswire/ -- Omi Medical Center, part of the Seikoukai Social Medical Corporation and one of Japan's leading institutions in the use of advanced medical technologies, announced it is partnering with TriNet... |
| 21.02.2023 | Chrysalis Advisory and TriNetX Establish a Strategic Collaboration to Support Research Teams Across Australia and New Zealand | CAMBRIDGE, Mass., Feb. 21, 2023 /PRNewswire/ -- TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced a strategic collaboration with Chrysalis Adv... |
| 27.01.2022 | TriNetX Announces the Appointment of Shogo Wakabayashi as Japan Country Manager | CAMBRIDGE, Mass., Jan. 27, 2022 /PRNewswire/ -- TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, has announced that Shogo Wakabayashi has joined the company ... |
| 01.11.2021 | TriNetX Announces the Appointment of Dr. Jeffrey Brown as Chief Scientific Officer | CAMBRIDGE, Mass., Nov. 1, 2021 /PRNewswire/ -- TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, has announced that Jeffrey Brown, PhD, is joining the company... |
| 26.02.2021 | Mark Mallon charts post-Ironwood course by taking CEO job at NeoGenomics; GlaxoSmithKline vet Feng Ren joins Insilico as CSO | Mark Mallon
→ Mark Mallon steps aside at Ironwood on March 12 after close to two years at the helm, and he already has a new change of scenery squared away. Beginning April 19, Mallon takes charge as CEO of cancer-focused geneti... |
| 17.02.2021 | TriNetX Expands the Breadth and Depth of its Global Research Network and Real-World Data Set Adding COVID-19 Vaccination Data to Longitudinal Patient Histories | |
| 22.01.2021 | COVID-19 Research Published in The Lancet Rheumatology Finds Rheumatic Disease Patients are at a Reduced Likelihood of Severe Outcomes Now vs. Early Days of Pandemic | |
| 09.11.2020 | New Research Published in The Lancet Psychiatry Finds COVID-19 Associated with Increased Risk for Developing Psychiatric Disorders | |
| 29.10.2020 | Medidata, TriNetX, Datavant Partner to Accelerate Use of RWD | What You Should Know:
– Today, Medidata, TriNetX, and Datavant announced a partnership to accelerate the use of real-world data (RWD) to power clinical research.
– Linking RWD, which is data not collected during the specific context of a cl... |
| 21.09.2020 | Carlyle Makes Strategic Growth Investment in TriNetX; Acquires Majority Stake in Leading Global Health Research Network | |
| 14.09.2020 | TriNetX Receives Fierce Innovation Award - Life Sciences Edition 2020 | |
| 10.09.2020 | New Study Published in PLOS Medicine Explores Impact of Race, Age & Comorbidities on COVID-19 Mortality | |
| 19.07.2019 | Some of the top precision health startups funded in 2019 | The precision medicine space is expected to grow to over $216.75 billion by 2028
Precision health, which is medicine that is tailored to each individual person, using their genes to figure out what treatments will work best for that individ... |
| 05.04.2019 | Boston Tech Watch: Huawei, Care.com, Cambridge Blockchain & PayPal | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Investors took restaurant technology startups out to lunch with monster nine-figure funding rounds. The Wall Street Journal investigation into Care.com leads investors to sue ... |
| 03.04.2019 | On the heels of a $40 million round, TriNetX brings its services for drug trials to Europe | The market for technology and services for clinical drug trials is expected to reach $68.9 billion over the next seven years. The trials, which are necessary to bring new healthcare treatments to market, are by necessity prolonged, complica... |
| 02.04.2019 | TriNetX Acquires European Clinical Data Network InSite | TriNetX’s acquisition of Belgium-based InSite Promises to Bring New Pharmaceutical-Sponsored Clinical Trials to Healthcare Organizations Throughout Europe.
TriNetX, a global health research network that revolutionizes clinical research and ... |
| 23.03.2019 | Cambridge-Based Health Research Network Company TriNetX Raises $40 Million | TriNetX, a Cambridge, Mass. based global health research network company that is transforming clinical research and enables discoveries through the generation of real-world evidence (RWE), announced it raised $40 million in Series D funding... |
| 18.03.2019 | TriNetX Raises $40M in Series D Funding | TriNetX, a Cambridge, Mass.-based global health research network, raised $40m in Series D financing.
The round, which brought total funding to $102m, was led by Merck Global Health Innovation Fund (Merck GHIF) along with new investors Mitsu... |
| 14.03.2019 | Daily funding roundup - March 14th, 2019 | StoryFit raised $1.75M; CryptoNumerics raised $2.5M; Gencove raised $3M; Fi $7M
StoryFit: StoryFit puts the power of artificial intelligence in the hands of publishers and studios. StoryFit has raised $1.75 million in new funding led by ff ... |
| 14.03.2019 | TriNetX raises $40M Series D for real-world evidence research platform | |
| 14.03.2019 | Term Sheet — Thursday, March 14 | ‘THE SIDE DOOR’
The college admissions cheating saga continues. New details are emerging around the scam, in which 50 people were accused for paying bribes to get their children into elite schools.
Paid Content Securing the enterprise witho... |
| 13.03.2019 | TriNetX raises $40 million to simplify clinical research | TriNetX, a health research company headquartered in Cambridge, Massachusetts, today announced that it has raised $40 million in an oversubscribed series D funding round led by Merck’s Global Health Innovation Fund, with participation from n... |
| 13.03.2019 | TriNetX raises $40 million to simplify clinical research | Did you miss a session from GamesBeat Summit 2022? All sessions are available to stream now. Learn more.
TriNetX, a health research company headquartered in Cambridge, Massachusetts, today announced that it has raised $40 million in an over... |
| - | From months to minutes: the need for speed in real-world evidence generation | By now, the story is cliché.
You notice an association between a set of baseline observations and a critical outcome. Or you suspect that the inclusion criteria on your next trial, a pivotal Phase 3, will disqualify too many patients. In an... |
| - | TriNetX | - |
